Last reviewed · How we verify

NCT07069088

This Study Aims to Characterize and Compare Patients of Adult-onset RA With Patients of Elderly-onset RA Based on the Clinical Manifestations, Disease Activity, Severity Parameters, and Therapeutic Features

Active, enrolled Last updated 16 July 2025
What this trial tests

trial in Rheumatoid Arthritis (RA) in 150 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 July 2025
Primary endpoint
1 January 2026
1 March 2026

Quick facts

Lead sponsorSohag University
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment150
Start date1 July 2025
Primary completion1 January 2026
Estimated completion1 March 2026
Sites1 location across Egypt

Conditions studied

Sponsor

Sohag University

Who can join

16 and older, any sex, with Rheumatoid Arthritis (RA). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to characterize and compare patients of adult-onset RA with patients of elderly-onset RA based on the clinical manifestations, disease activity, severity parameters, and therapeutic features.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Rheumatoid Arthritis (RA)

Currently open trials in the same condition.

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07069088.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing